Early-stage kidney damage from diabetes can often be slowed, stopped, or partially reversed with aggressive blood sugar control and the right medications. Once significant scarring has occurred in the kidneys, though, that structural damage is permanent. The key factor is how early you catch it: damage detected when only small amounts of protein are leaking into your urine (a sign the kidney filters are stressed but not destroyed) responds far better to treatment than advanced disease where large amounts of protein are spilling over and kidney function is dropping.
Good evidence shows that early treatment delays or prevents the progression of diabetic kidney disease in both type 1 and type 2 diabetes. That makes understanding your current stage, and acting on it quickly, the most important thing you can do.
How Kidney Damage From Diabetes Is Staged
Diabetic kidney disease is tracked with two numbers: your estimated glomerular filtration rate (eGFR), which measures how well your kidneys filter blood, and your urine albumin-to-creatinine ratio (UACR), which measures how much protein is leaking through your kidney filters. Together, these tell you where you stand.
An eGFR of 90 or higher is normal (stage G1). Between 60 and 89 is mildly reduced (G2). Stages G3a (45 to 59), G3b (30 to 44), and G4 (15 to 29) represent moderate to severe loss. Below 15 is kidney failure (G5). For protein leakage, a UACR under 30 is normal, 30 to 300 is moderately increased (sometimes called microalbuminuria), and above 300 is severely increased.
The earlier your numbers are caught moving in the wrong direction, the more reversible the damage is. Someone with a normal eGFR but a UACR creeping above 30 has a window where treatment can push protein levels back to normal and preserve kidney function for decades. Someone already at stage G4 with heavy protein loss is working to slow progression, not reverse it.
Blood Sugar Control Is the Foundation
High blood sugar damages the tiny blood vessels inside your kidneys over years. Bringing your A1C down reduces the strain on those vessels and gives the kidney filters room to recover. There’s no single magic number, but getting your A1C below 7% (or whatever target your doctor sets based on your situation) consistently is the most reliable way to slow kidney decline.
This doesn’t require perfection. Sustained improvement matters more than hitting a number once. Even modest reductions in A1C, if maintained over months and years, translate into measurably less kidney damage. The medications discussed below can help with blood sugar and offer direct kidney protection at the same time.
Medications That Protect the Kidneys
Blood Pressure Medications (ACE Inhibitors and ARBs)
High blood sugar isn’t the only force damaging your kidneys. High blood pressure compounds the problem by pushing too hard against the delicate filters (called glomeruli) inside each kidney. ACE inhibitors and ARBs specifically target this by relaxing the blood vessels in and around the kidneys, lowering the pressure on those filters and giving them a chance to rest and heal. Both drug classes also reduce the amount of protein leaking into your urine, which is itself a sign of filter damage. If you have diabetic kidney disease with any degree of protein leakage, one of these medications is typically part of the treatment plan even if your blood pressure isn’t especially high.
SGLT2 Inhibitors
SGLT2 inhibitors (drugs like empagliflozin, dapagliflozin, and canagliflozin) were originally developed to lower blood sugar, but they turned out to have a powerful kidney-protective effect that goes beyond glucose control. They reduce the pressure inside the kidney filters through a separate mechanism from ACE inhibitors, and the two classes work well together. Large clinical trials have shown these drugs slow the decline in kidney function, reduce protein leakage, and lower the risk of progressing to kidney failure. They’ve become a standard part of treatment for diabetic kidney disease at multiple stages.
GLP-1 Receptor Agonists
GLP-1 receptor agonists (the drug class that includes semaglutide and liraglutide) also provide kidney benefits on top of blood sugar and weight management. A large meta-analysis published in The Lancet Diabetes & Endocrinology found that in people with type 2 diabetes, these drugs reduced a composite of serious kidney events by 18% and kidney failure specifically by 16% compared to placebo. They also cut cardiovascular events by 13% and overall death by 12%, which matters because heart disease and kidney disease fuel each other in diabetes. Side effects leading to stopping the medication were more common with GLP-1 drugs (mostly gastrointestinal issues like nausea), but serious adverse events like pancreatitis or severe low blood sugar were not increased.
Finerenone
Finerenone is a newer medication that blocks a hormone pathway contributing to inflammation and scarring in the kidneys and heart. In a trial of nearly 5,734 patients with advanced diabetic kidney disease (the FIDELIO-DKD trial), finerenone reduced kidney disease progression by 18% and cardiovascular death by 14% over about 2.6 years. A second trial (FIGARO-DKD) in over 7,400 patients with less advanced kidney disease found a 13% reduction in a composite of cardiovascular events and a trend toward slower kidney decline over 3.4 years. This drug is now used alongside ACE inhibitors or ARBs in people who still have significant protein leakage despite other treatments.
Dietary Changes That Make a Difference
Sodium is the dietary factor with the clearest impact on kidney protection. High sodium intake raises blood pressure, which directly increases the pressure on kidney filters. The National Kidney Foundation recommends that people with kidney disease or high blood pressure aim for no more than 1,500 mg of sodium per day, compared to the general guideline of 2,300 mg. Most of the sodium in a typical diet comes from processed and restaurant foods, not the salt shaker, so the practical shift involves cooking more at home and reading labels.
Protein intake is another consideration. Your kidneys have to work harder to process protein, so very high-protein diets can accelerate damage. This doesn’t mean going extremely low-protein, which can cause its own problems. A moderate protein intake, roughly in line with standard dietary guidelines rather than the high levels common in weight-loss or fitness diets, is the general approach. A dietitian familiar with kidney disease can help you find the right balance based on your stage.
Potassium and phosphorus restrictions become more important at later stages of kidney disease when the kidneys can no longer regulate these minerals well. In early stages, the priority is sodium, blood sugar management through carbohydrate quality, and maintaining a healthy weight.
How Much Reversal Is Realistic
True reversal, where kidney function returns to normal and stays there, is most achievable in the earliest stages. If your only abnormal finding is mildly elevated protein in the urine (UACR between 30 and 300) with a preserved eGFR, aggressive treatment can normalize that protein level. This is sometimes called “regression of albuminuria,” and it’s associated with a dramatically lower risk of progressing to more advanced kidney disease.
Once eGFR drops below 60 and protein leakage is heavy, the realistic goal shifts from reversal to stabilization. The kidney tissue that has scarred won’t regenerate, but the remaining healthy tissue can be preserved for years or even decades with the right combination of medications and lifestyle changes. Many people stabilize at a reduced but functional level of kidney function and never progress to dialysis.
At very advanced stages (eGFR below 30), the focus is on slowing the rate of decline and managing complications like fluid retention, blood pressure spikes, and mineral imbalances. Even here, the medications described above can meaningfully extend the time before dialysis or transplant becomes necessary.
Monitoring and Staying on Track
Kidney damage from diabetes is often silent until it’s advanced. You won’t feel protein leaking into your urine, and you likely won’t notice a gradual eGFR drop until it’s significant. Regular blood and urine testing is the only way to catch changes early. Most guidelines recommend checking both eGFR and UACR at least once a year if you have diabetes, and more frequently if you’ve already been diagnosed with kidney disease.
Tracking your A1C every three months, keeping blood pressure consistently below 130/80 (or the target your provider sets), and taking your medications without gaps are the practical behaviors that drive outcomes. The combination of tight blood sugar control, blood pressure management with a kidney-protective medication, and one or more of the newer drug classes now available has fundamentally changed the outlook for diabetic kidney disease compared to even a decade ago. The earlier you start, the more kidney function you keep.